Citrin缺陷导致的生长发育落后和血脂异常：一种新的临床表现型

摘要
图/表
参考文献(23)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (1303 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要 Citrin缺陷病 (citrin deficiency, CD)已报道两种临床表现型，一种是成人发病瓜氨酸血症Ⅱ型 (CTLN2)，另一种是citrin缺陷导致的新生儿肝内胆汁淤积症(NICCD)。该文报道1例以生长发育落后和血脂异常为主要临床表现的男性CD幼儿。患儿1岁6月时体重和身长均低于相应WHO体格测量百分位表上的第3百分位数，同时血生化分析发现甘油三酯和总胆固醇水平显著增高，伴高密度脂蛋白胆固醇降低。病史询问发现患儿1岁后有难以纠正的厌食米饭而嗜食鱼肉的饮食习惯。偏食倾向2岁后更明显，血氨基酸分析显示瓜氨酸和苏氨酸轻度增高，于是该患儿在2岁5月时被怀疑为CD。按患儿饮食嗜好自然喂养之后，其生长发育落后逐渐改善，体重在3岁时恢复到第3百分位数以上，血脂逐渐恢复正常。SLC25A13突变分析表明患儿是851del4的纯合子。据此，患儿被确诊为CD。4岁7月时的饮食调查表明患儿有典型的低碳水化合物和高蛋白饮食倾向——厌食米饭，而嗜好海鲜、肉类、蛋类和奶类。该患儿主要临床表现为生长发育落后和血脂异常，为一种不同于NICCD 和CTLN2的新的CD表现型。［中国当代儿科杂志，2009，11（5）：328-332］

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	宋元宗
	郭丽
	杨艳玲
	韩连书
	小林圭子
	佐伯武赖

关键词 ： Citrin缺陷, 血脂异常, 生长发育落后, 儿童

Abstract：Two clinical phenotypes for citrin deficiency (CD) have been reported. One is adult-onset citrullinemia type II (CTLN2) and another is neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). A child with CD and who had failure to thrive (FTT) and dyslipidemia as main clinical manifestations is reported here. Both the weight-and length-for-age at 18 months dropped below the 3rd percentile in the corresponding WHO anthropometry percentile charts, while blood biochemical analysis revealed dramatically increased triglyceride and total cholesterol, together with reduced HDL-cholesterol. Inquiries revealed his aversion to rice and fondness for fish since the age of one year, a peculiar habit which could not be corrected. Since the age of two years, the peculiar diet became more obvious, and slightly increased citrulline and threonine levels were detected on blood amino acid analysis. At the age of two years and five months he was suspected to have CD. Since then, he has been fed in accordance with his own food preferences, and FTT improved gradually, with weight-for-age, in particular, recovering beyond the 3rd percentile at three years of age, and dyslipidemia was also ameliorated gradually. SLC25A13 gene analysis revealed a homozygote of 851del4, and CD was thus confirmed. Diet survey at four years and seven months revealed a fondness for high-protein and low-carbohydrate foods, such as seafood, meat, eggs and milk. This child presented with FTT and dyslipidemia as main clinical manifestations and this was a novel CD phenotype different from NICCD and CTLN2.［Chin J Contemp Pediatr, 2009, 11 (5):328-332］

Key words： Citrin deficiency Dyslipidemia Failure to thrive Child

PACS:	R589
	R596

引用本文:

宋元宗,郭丽,杨艳玲等. Citrin缺陷导致的生长发育落后和血脂异常：一种新的临床表现型[J]. 中国当代儿科杂志, 2009, 11(05): 328-332.

SONG Yuan-Zong,GUO Li,YANG Yan-Ling et al. Failure to thrive and dyslipidemia caused by citrin deficiency: a novel clinical phenotype[J]. CJCP, 2009, 11(05): 328-332.

链接本文:

http://www.zgddek.com/CN/ 或 http://www.zgddek.com/CN/Y2009/V11/I05/328

	［1］Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein［J］. Nat Genet, 1999, 22(2):159-163.
	［2］Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD) ［J］. J Hum Genet, 2002, 47(7):333-341.
	［3］Ohura T, Kobayashi K, Tazawa Y, Abukawa D, Sakamoto O, Tsuchiya S, et al.Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) ［J］. J Inherit Metab Dis, 2007, 30(2):139-144.
	［4］Yazaki M, Takei Y, Kobayashi K, Saheki T, Ikeda S. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adultonset type II citrullinemia (CTLN2) ［J］. Intern Med, 2005, 44(3):188-195.
	［5］杨艳玲,田上泰子,佐伯武赖,小林圭子,李孟贤,花井润师,等. 成人瓜氨酸血症II型一家系分析［J］. 中华医学遗传学杂志, 2003, 20(5):380.
	［6］宋元宗,郝虎,牛飼美晴,柳国胜,肖昕,佐伯武赖,等. 疑难病研究Citrin缺陷导致的新生儿肝内胆汁淤积症［J］. 中国当代儿科杂志, 2006, 8(2):125-128.
	［7］Kobayashi K, Shaheen N, Kumashiro R, Tanikawa K, O′Brien WE, Beaudet AL, et al. A search for the primary abnormality in adult-onset type II citrullinemia［J］. Am J Hum Genet, 1993, 53(5):1024-1030.
	［8］Shigematsu Y, Hirano S, Hata I, Tanaka Y, Sudo M, Sakura N, et al. Newborn mass screening and selective screening using electrospray tandem mass sprctrometry in Japan［J］. J Chromatogr B, 2002, 776(1):39-48.
	［9］Yamaguchi N, Kobayashi K, Yasuda T, Nishi I, Iijima M, Nakagawa M, et al. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations［J］. Hum Mutat, 2002, 19(2):122-130.
	［10］宋元宗,牛飼美晴,盛建胜,飯島幹雄,小林圭子. Citrin缺陷导致的新生儿肝内胆汁淤积症家系SLC25A13基因突变研究［J］. 中华儿科杂志, 2007, 45(6):408-412.
	［11］Olsen EM, Petersen J, Skovgaard AM, Weile B, Jorgensen T, Wright CM. Failure to thrive: the prevalence and concurrence of anthropometric criteria in a general infant population［J］. Arch Dis Child, 2007, 92(2):109-114.
	［12］Saheki T, Kobayashi K, Iijima M, Nishi I, Yasuda T, Yamaguchi N, et al. Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency［J］. Metab Brain Dis, 2002, 17(4):335-346.
	［13］Saheki T, Kobayashi K, Terashi M, Ohura T, Yanagawa Y, Okano Y, et al. Reduced carbohydrate intake in citrin-deficient subjects［J］. J Inherit Metab Dis, 2008, 31(3):386-394.
	［14］Saheki T, Kobayashi K, Iijima M, Moriyama M, Yazaki M, Takei Y,et al. Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier［J］. Hepatol Res, 2005, 33(2):181-184.
	［15］Saheki T, Kobayashi K, Iijima M, Horiuchi M, Begum L, Jalil MA, et al. Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle［J］. Mol Genet Metab, 2004, 81(Suppl 1):S20-S26.
	［16］Dimmock D, Kobayashi K, Iijima M, Tabata A, Wong LJ, Saheki T, et al. Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet［J］. Pediatrics, 2007, 119(3):e773-777.
	［17］Dimmock D, Maranda B, Dionisi-Vici C, Wang J, Kleppe S, Fiermonte G, et al. Citrin deficiency, a perplexing global disorder［J］. Mol Genet Metab, 2009, 96(1):44-49.
	［18］Takahashi H, Kagawa T, Kobayashi K, Hirabayashi H, Yui M, Begum L, et al. A case of adult-onset type II citrullinemia-deterioration of clinical course after infusion of hyperosmotic and high sugar solutions［J］. Med Sci Monit, 2006, 12(2):CS13-15.
	［19］Yazaki M, Takei Y, Kobayashi K, Saheki T, Ikeda S. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adultonset type II citrullinemia (CTLN2)［J］. Intern Med, 2005, 44(3):188-195.
	［20］Song YZ, Li BX, Chen FP, Liu SR, Sheng JS, Ushikai M, et al. Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China［J］. Dig Liver Dis, 2009, Epub ahead of print.
	［21］Tsai CW, Yang CC, Chen HL, Hwu WL, Wu MZ, Liu KL, et al. Homozygous SLC25A13 mutation in a Taiwanese patient with adult-onset citrullinemia complicated with steatosis and hepatocellular carcinoma［J］. J Formos Med Assoc, 2006, 105(10):852-856.
	［22］Soeda J, Yazaki M, Nakata T, Miwa S, Ikeda S, Hosoda W, et al. Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report［J］. J Clin Gastroenterol, 2008, 42(7):855-860.
	［23］Lu YB, Kobayashi K, Ushikai M, Tabata A, Iijima M, Li MX, et al. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency［J］. J Hum Genet, 2005, 50(7):338-346.